MAPK recruitment by β‐amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time
Open Access
- 10 September 2004
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 91 (2) , 349-361
- https://doi.org/10.1111/j.1471-4159.2004.02722.x
Abstract
Elevated β-amyloid is thought to trigger the onset of Alzheimer's disease. Alzheimer's disease is marked by progressive loss of cognitive function, an early symptom of which is episodic memory deficits. Impairment of episodic memory is linked to hippocampal pathology. We investigated the signal transduction consequences of exposure to nanomolar to low micromolar concentrations of aggregate forms of β-amyloid in the hippocampus. We found that, in addition to activation of ERK MAPK and its downstream target ribosomal S6 kinase in hippocampal slice cultures following acute exposure to oligomeric β-amyloid1−42, ERK activation also requires phosphoinositide-3 kinase activity. These effects were contingent on the α7 subtype of nicotinic acetylcholine receptor. Hippocampal slice cultures treated acutely with oligomeric β-amyloid1−42 did not exhibit JNK MAPK activation; however, chronic exposure to oligomers or high molecular weight aggregates of β-amyloid1−42 led to JNK MAPK activation coincident with ERK MAPK down-regulation. In contrast to the effects of acute application of oligomeric β-amyloid1−42, nicotine activated ERK MAPK via α7 nicotinic acetylcholine receptors utilizing protein kinase A as an intermediate. In conclusion, we found that both the physical state and duration of exposure to β-amyloid are determinants of MAPK recruitment in hippocampus. We also found that nicotine and β-amyloid activate ERK MAPK via α7 nicotinic acetylcholine receptors but use distinct intermediate kinases. These data indicate the existence of differential coupling of α7 to downstream targets depending on the type of ligand that leads to receptor activation.Keywords
This publication has 74 references indexed in Scilit:
- Mouse strain‐specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampusJournal of Comparative Neurology, 2003
- MAP Kinase Signaling Cascade Dysfunction Specific to Alzheimer's Disease in FibroblastsNeurobiology of Disease, 2002
- Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cellsGlia, 2001
- Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive DeclineJAMA, 2000
- Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 1999
- The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic AgingExperimental Neurology, 1999
- Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neuritesBrain Research, 1993
- Quantitative Changes in Mesial Temporal Volume, Regional Cerebral Blood Flow, and Cognition in Alzheimer's DiseaseArchives of General Psychiatry, 1992
- A simple method for organotypic cultures of nervous tissueJournal of Neuroscience Methods, 1991
- Development of glutamate binding sites and their regulation by calcium in rat hippocampusDevelopmental Brain Research, 1981